Startup · AI
Jobs at Kymera Therapeutics
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer. 28 open roles.
See all 28 roles →Find your next role52208 open roles
Open roles
Jobs at Kymera Therapeutics
28open roles
$180K to $275Ktypical pay · salary guide
Updated weekly.
Last refresh Mon, Sep 28
Showing 21 to 28 of 28 jobs
- Senior or Executive Director, AI Strategy & Applications AIKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$235K to $335K
- Associate Director, Clinical OperationsKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$160K to $240K
- Director or Senior Director, Regulatory AffairsKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $330K
- Senior Scientist or Principal Scientist, Targeted ProteomicsKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$115K to $215K
- Vice President, Pharmaceutical DevelopmentKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$315K to $395K
- Director, Trial Master FileKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$195K to $275K
- Clinical Trial ManagerKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$115K to $200K
- Senior Manager or Associate Director, Strategic SourcingKymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation. Backed by Bessemer.$145K to $240K
Build your edge while you search
Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.